Rockefeller Capital Management
CCXI

Rockefeller Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Rockefeller Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-65
Closed -$3K – 4409
2022
Q3 		$3K Hold
65
– – ﹤0.01% 3540
2022
Q2 		$1K Buy
+65
New +$1.43K ﹤0.01% 4066

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rockefeller Capital Management's CCXI Position: Q4 2022 in Review

Rockefeller Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 65 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in CCXI in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Rockefeller Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 65 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3K.
  • Rockefeller Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2022 and held it in 2 quarters.
  • Rockefeller Capital Management's ChemoCentryx, Inc. position peaked at $3K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Rockefeller Capital Management's 13F filing for Q4 2022, filed 6 Mar 2023.